Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

被引：3848
|
作者：
Fischereder, Michael [1 ]
Schoenermarck, Ulf [1 ]
机构：
[1] Klinikum Ludwig Maximilians Univ Munich, Munich, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 11期
关键词：
D O I：
10.1056/NEJMc1600827
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1092 / 1093
页数：2
相关论文
共 50 条
  • [11] Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes
    Aronow, Wilbert S.
    Shamliyan, Tatyana A.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [12] EFFECT OF EMPAGLIFLOZIN ON MORTALITY AND CAUSES OF DEATH IN PATIENTS WITH TYPE 2 DIABETES AT HIGH CARDIOVASCULAR RISK
    Fitchett, David H.
    Inzucchi, Silvio
    Lachin, John
    Wanner, Christoph
    Mattheus, Michaela
    Johansen, Odd Erik
    Woerle, Hans-Juergen
    Broedl, Uli C.
    Zinman, Bernard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1869 - 1869
  • [13] Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Sattar, Naveed
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Zethelius, Bjorn
    Miftaraj, Mervete
    McGuire, Darren K.
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (07): : 633 - 644
  • [14] Empagliflozin and cardiovascular endpoints in patients with type 2 diabetes mellitus
    Guthoff M.
    [J]. Der Nephrologe, 2016, 11 (3): : 217 - 218
  • [15] Usefulness of Empagliflozin Versus Oral Semaglutide for Prevention of Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus
    Hammerman, Ariel
    Moore, Candace Makeda
    Aboalhasan, Enis
    Azuri, Joseph
    Arbel, Ronen
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2022, 170 : 128 - 131
  • [16] Comparison of Cardiovascular Outcomes Between Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes: A Meta-Analysis
    Memon, Rahat A.
    Akbariromani, Hanieh
    Vohra, Rimsha R.
    Kundi, Hayan
    Saleem, Rao Faraz
    Ghaffari, Muhammad Abuzar
    Haas, Donald
    Khan, Areeba
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [17] Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes
    Singh, Sahib
    Garg, Aakash
    Tantry, Udaya S.
    Bliden, Kevin
    Gurbel, Paul A.
    Gulati, Martha
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2024, 218 : 24 - 31
  • [18] Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
    Lim, Jayoung
    Hwang, In-Chang
    Choi, Hong-Mi
    Yoon, Yeonyee E.
    Cho, Goo-Yeong
    [J]. PLOS ONE, 2022, 17 (10):
  • [19] Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
    Wanner, Christoph
    Lachin, John M.
    Inzucchi, Silvio E.
    Fitchett, David
    Mattheus, Michaela
    George, Jyothis
    Woerle, Hans J.
    Broedl, Uli C.
    von Eynatten, Maximilian
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    [J]. CIRCULATION, 2018, 137 (02) : 119 - 129
  • [20] Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes
    Kramer, Bernhard K.
    Hauske, Sibylle J.
    Chilton, Robert
    Mann, Johannes F. E.
    Gullestad, Lars
    Fitchett, David
    Mattheus, Michaela
    Steubl, Dominik
    Wanner, Christoph
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (09)
12345